Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. [electronic resource]
Producer: 20090820Description: 3650-8 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Arsenic Trioxide
- Arsenicals -- administration & dosage
- Blood Chemical Analysis
- Bone Marrow -- pathology
- Cohort Studies
- Confidence Intervals
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Leukemia, Promyelocytic, Acute -- drug therapy
- Male
- Middle Aged
- Monitoring, Physiologic -- methods
- Multivariate Analysis
- Neoplasm Recurrence, Local -- diagnosis
- Neoplasm, Residual -- diagnosis
- Oncogene Proteins, Fusion -- genetics
- Oxides -- administration & dosage
- Predictive Value of Tests
- Probability
- Prognosis
- Proportional Hazards Models
- Prospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
- Tretinoin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.